Fabrizio Chiodo studies adaptive and innate responses of non-mammalian glyco-conjugates, mostly in the context of vaccines and host-pathogen interactions. During his PhD (defended in 2013, San Sebastian, Spain), working on a new generation of vaccines technology he had a long stay at the Amsterdam Medical Center. In 2014 he started his independent research working at the Leiden Institute of Chemistry and Leiden University Medical Center. He initiated and strengthened International collaborations in the field of vaccinology especially with the Finlay Institute in Cuba, where he is an associate researcher and invited lecturer at the Faculty of Chemistry. In 2018 he moved to the Amsterdam Infection and Immunity Institute working independently as senior researcher. From October 2020 he is a research assistant professor at the Italian National Research Institute (CNR) working at the Institute of Biomolecular Chemistry, Naples, keeping his affiliation and position also in Amsterdam. He has been involved in the design and development of SARS-CoV-2 Soberana vaccines developed by Finlay Institute in Cuba. From 2023 he is a research associate professor at CNR.